Publications, press articles, rankings, awards
14
02, 2024
Cour de Cassation, Commercial Chamber, 31 January 2024 – Decision No. 22-20.293
8
02, 2024
The Italy and the Unified Patent Court (UPC) have signed a headquarters agreement, see press release of the Italian government.
31
01, 2024
The Pharma and Biotech Patent Litigation Europe summit which has taken place in Amsterdam was a good opportunity to get an overview from the EPO of the state of play.
12
01, 2024
Recently, the annual IP5 Statistics Report of the world’s five largest IP offices (IP5) was issued.
26
12, 2023
Lavoix presents a review of pharmaceutical trademark and design decisions handed down by French and European Union courts.
19
12, 2023
The EPO has announced that the notice from the EPO informing about the entry into the European phase before the EPO is discontinued.
12
12, 2023
Created more than 10 years ago to gain a better understanding of developments in intellectual property, the IP Barometer also enables us to develop our services to better meet our clients’ expectations in terms of protecting and enhancing the value of their intangible assets.
23
11, 2023
The Enlarged Board of Appeal issued a decision on the consolidated referrals G 1/22 and G 2/22, ruling that the EPO is competent to assess entitlement to priority and that the “PCT joint applicants” approach is valid.
13
11, 2023
Patent fees will increase up to 36% in Canada as from January 1st, 2024.
26
10, 2023
A new fiction for notification and time limit calculation will enter into force on November 1st, 2023.